comparemela.com

Latest Breaking News On - Brian silver - Page 5 : comparemela.com

MedRhythms Launches Clinical Trial of Stroke Asset on Walking Outcomes

MedRhythms Launches Clinical Trial of Stroke Asset on Walking Outcomes MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, announces the launch of a clinical trial that will study MR-010, MedRhythms’ acute stroke asset. The trial, conducted in partnership with and funded by UMass Memorial Healthcare, will examine the impact of MR-010 on acute stroke walking outcomes. Led by Dr. Brian Silver, Interim Chair in the UMass Department of Neurology, the trial will assess the feasibility of MR-010 to address walking impairments in those in the acute phase of stroke. It will consist of two phases: the first phase will look at the impact of MR-010 within the acute hospital setting, and the second phase will look at the continued impact of the therapeutic post-discharge, MedRhythms notes in a media release.

MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke

MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke News provided by Share this article Share this article PORTLAND, Maine, April 28, 2021 /PRNewswire/ MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the launch of a clinical trial that will study MR-010, MedRhythms acute stroke asset. The trial will be in partnership with UMass Memorial Healthcare and will examine the impact of MR-010 on acute stroke walking outcomes. Stroke is the world s top cause of long-term disability due to the high prevalence of stroke across the globe as well as its devastating health impacts. Over a third of stroke survivors live in the United States and, according to the CDC, approximately 800,000 people in the US suffer a stroke annually.

MedRhythms to test digital therapy for acute stroke, add hires

MedRhythms, a Portland-based digital health startup that uses sensors, software and music to help restore function lost to neurologic disease or injury, on Wednesday announced the launch of a clinical trial related to acute stroke. The trial will be in partnership with UMass Memorial Healthcare and will examine the effect of a solution developed by the company on walking by patients with acute stroke.  Wednesday s announcement comes as MedRhythms prepares to launch a trial in collaboration with Boston University related to Parkinson s disease in the next few weeks, and amid an ongoing pivotal trial related to chronic stroke that has been expanded to eight trial sites.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.